BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21819911)

  • 21. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.
    Burrel M; Llovet JM; Ayuso C; Iglesias C; Sala M; Miquel R; Caralt T; Ayuso JR; Solé M; Sanchez M; Brú C; Bruix J;
    Hepatology; 2003 Oct; 38(4):1034-42. PubMed ID: 14512891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation.
    Baird AJ; Amos GJ; Saad NF; Benson MD
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):314-20. PubMed ID: 23721140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
    Choi JW; Lee JM; Kim SJ; Yoon JH; Baek JH; Han JK; Choi BI
    Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of T2*-weighted multi-echo GRE imaging as a novel method to diagnose hepatocellular carcinoma compared with gadolinium-enhanced MRI: a feasibility study.
    Hardie AD; Romano PB
    Magn Reson Imaging; 2010 Feb; 28(2):281-5. PubMed ID: 20071122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-contrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis.
    Hanna RF; Kased N; Kwan SW; Gamst AC; Santosa AC; Hassanein T; Sirlin CB
    AJR Am J Roentgenol; 2008 Jan; 190(1):47-57. PubMed ID: 18094293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma missed on gadolinium enhanced MR imaging, discovered in liver explants: retrospective evaluation.
    Karadeniz-Bilgili MY; Braga L; Birchard KR; Gerber D; Firat Z; Woosley JT; Shrestha R; Semelka RC
    J Magn Reson Imaging; 2006 Feb; 23(2):210-5. PubMed ID: 16416439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?
    Chandarana H; Robinson E; Hajdu CH; Drozhinin L; Babb JS; Taouli B
    AJR Am J Roentgenol; 2011 May; 196(5):1083-9. PubMed ID: 21512074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.
    Rimola J; Forner A; Tremosini S; Reig M; Vilana R; Bianchi L; Rodríguez-Lope C; Solé M; Ayuso C; Bruix J
    J Hepatol; 2012 Jun; 56(6):1317-23. PubMed ID: 22314420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration.
    Golfieri R; Grazioli L; Orlando E; Dormi A; Lucidi V; Corcioni B; Dettori E; Romanini L; Renzulli M
    J Magn Reson Imaging; 2012 Sep; 36(3):648-57. PubMed ID: 22592930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
    Kim S; Mannelli L; Hajdu CH; Babb JS; Clark TW; Hecht EM; Taouli B
    J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
    Kim JH; Kim MJ; Park YN; Lee JT; Kim BR; Chung JB; Choi JS; Kim KS; Kim KW
    Clin Radiol; 2008 Nov; 63(11):1195-204. PubMed ID: 18929037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: tumor-by-tumor analysis in explant livers.
    Nakamura Y; Tashiro H; Nambu J; Ohdan H; Kakizawa H; Date S; Awai K
    J Magn Reson Imaging; 2013 Mar; 37(3):684-91. PubMed ID: 23055436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the diagnostic accuracy of T2*-weighted MR imaging for identifying hepatocellular carcinoma with liver explant correlation.
    Hardie AD; Nance JW; Boulter DJ; Kizziah MK
    Eur J Radiol; 2011 Dec; 80(3):e249-52. PubMed ID: 21112710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging.
    van den Bos IC; Hussain SM; Terkivatan T; Zondervan PE; de Man RA
    J Magn Reson Imaging; 2006 Nov; 24(5):1071-80. PubMed ID: 17024654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study.
    Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK
    Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
    Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
    J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of diffusion-weighted MRI for identifying hepatocellular carcinoma with liver explant correlation.
    Hardie AD; Kizziah MK; Boulter DJ
    J Med Imaging Radiat Oncol; 2011 Aug; 55(4):362-7. PubMed ID: 21843170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.